GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » EPS without NRI

Frontage Holdings (HKSE:01521) EPS without NRI : HK$0.05 (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings EPS without NRI?

Frontage Holdings's earnings per share without non-recurring items for the six months ended in Dec. 2024 was HK$0.03. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.05.

During the past 12 months, Frontage Holdings's average earnings per share (NRI) Growth Rate was -44.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -24.20% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -5.90% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Frontage Holdings's EPS without NRI or its related term are showing as below:

HKSE:01521' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -24.2   Med: 12.85   Max: 44.2
Current: -24.2

During the past 9 years, Frontage Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 44.20% per year. The lowest was -24.20% per year. And the median was 12.85% per year.

HKSE:01521's 3-Year EPS without NRI Growth Rate is ranked worse than
85.26% of 1214 companies
in the Biotechnology industry
Industry Median: 12.35 vs HKSE:01521: -24.20

Frontage Holdings's EPS (Diluted) for the six months ended in Dec. 2024 was HK$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00.

Frontage Holdings's EPS (Basic) for the six months ended in Dec. 2024 was HK$0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.00.


Frontage Holdings EPS without NRI Historical Data

The historical data trend for Frontage Holdings's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontage Holdings EPS without NRI Chart

Frontage Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only 0.08 0.12 0.14 0.09 0.05

Frontage Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.04 0.05 0.02 0.03

Competitive Comparison of Frontage Holdings's EPS without NRI

For the Biotechnology subindustry, Frontage Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Frontage Holdings's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Frontage Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Frontage Holdings's PE Ratio without NRI falls into.


;
;

Frontage Holdings EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Frontage Holdings  (HKSE:01521) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Frontage Holdings EPS without NRI Related Terms

Thank you for viewing the detailed overview of Frontage Holdings's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Frontage Holdings Business Description

Traded in Other Exchanges
N/A
Address
700 Pennsylvania Drive, Exton, PA, USA, 19341
Frontage Holdings Corp provides laboratory and related services to pharmaceutical and agrochemical companies. Its segments include North America and Europe segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the USA, Canada and Europe; and PRC segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the PRC. It derives majority of the revenue from North America and Europe segment. Geographically majority of the revenue is derived from USA and Canada.
Executives
Li Song 2101 Beneficial owner
Hongkong Tigermed Co., Limited
Hang Zhou Tai Ge Yi Yao Ke Ji Gu Fen You Xian Gong Si 2101 Beneficial owner
Kabouter Management Llc 2102 Investment manager
Hangzhou Tigermed Consulting Co., Ltd.

Frontage Holdings Headlines

No Headlines